John Patrick Banovetz, Executive Vice President, on July 23, 2026, sold 7,880 shares in 3m (MMM) for $1,343,067. Following the Form 4 filing with the SEC, Banovetz has control over a total of 50,057 common shares of the company, with 50,057 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/66740/000006674026000255/xslF345X05/form4.xml
Ludmila Smolyansky, Member of 10% Owner Group, on July 22, 2026, sold 100,000 shares in Lifeway Foods (LWAY) for $3,011,400. Following the Form 4 filing with the SEC, Smolyansky has control over a total of 507,207 common shares of the company, with 507,207 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/814586/000168316826005734/xslF345X05/ownership.xml
Martine A Rothblatt, Director, Chairperson & CEO, on July 22, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,040,380. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 748,828 common shares of the company, with 40,513 shares held directly and 708,315 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000104/xslF345X05/primarydocument.xml
Nancy Koskey Patzwahl, Director, on July 22, 2026, executed a purchase for 25,000 shares in Rhinebeck Bancorp (RBKB) for $298,500. Following the Form 4 filing with the SEC, Patzwahl has control over a total of 27,270 common shares of the company, with 27,270 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1751783/000143774926024324/xslF345X05/rdgdoc.xml